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Vibrio vulnificus is a pathogenic bacterium that causes gastroenteritis and primary septicemia. To identify
factors involved in microbial adherence to the host cells, we investigated bacterial proteins capable of binding
to fibronectin, one of the main components comprised of the extracellular matrix of mammalian cells. A protein
of 35 kDa was purified from the extracts of V. vulnificus by its property to bind to immobilized fibronectin.
This protein was identified as OmpU, one of the major outer membrane proteins of V. vulnificus. In binding
assays using immobilized fibronectin, the number of ompU mutant cells bound to fibronectin was only 4% of
that of wild-type cells bound to fibronectin. In addition, the exogenous addition of antibodies against OmpU
resulted in a decreased ability of wild-type V. vulnificus to adhere to fibronectin. The ompU mutant was also
defective in its adherence to RGD tripeptide (5% of the adherence of the wild type to RGD), cytoadherence to
HEp-2 cells (7% of the adherence of the wild type to HEp-2), cytotoxicity to cell cultures (39% of the cytotoxicity
of the wild type), and mortality in mice (10-fold increase in the 50% lethal dose). The ompU mutant comple-
mented with the intact ompU gene restored its abilities for adherence to fibronectin, RGD tripeptide, and
HEp-2 cells; cytotoxicity to HEp-2 cells; and mouse lethality. This study indicates that OmpU is an important
virulence factor involved in the adherence of V. vulnificus to the host cells.
Vibrio vulnificus is a gram-negative pathogenic bacterium
that is encapsulated, motile, and invasive. This pathogen
causes primary septicemia, necrotizing wound infections, and
gastroenteritis, especially in humans with a heavy alcohol
drinking habit or hepatic diseases (24). Several virulence fac-
tors have been proposed for V. vulnificus: lipopolysaccharide
(2, 19), capsular polysaccharide (42), a cytolytic hemolysin
(10), an elastase (22), iron availability (43), and phospholipase
A2 (38). Genetic studies using knockout mutants of V. vulnifi-
cus vvpA (cytolysin) or vvpE (elastase) did not provide any
evidence supporting that they were key virulence factors caus-
ing lethality of mice or death of HEp-2 cells (12, 35, 40).
However, the cytolysin, but not the metalloprotease, was es-
sential for causing damage in tissues of the infected mice (7).
On the contrary, an important role of capsular polysaccharide
was demonstrated by measuring attenuated mouse lethality of
noncapsulated mutant V. vulnificus (45). Type IV pilin was also
confirmed to be involved in the virulence of V. vulnificus via a
genetic deletion of pilD or pilA gene (26, 27). In addition,
motility was discovered to be a virulence determinant of V.
vulnificus (15, 17).
Besides the structural apparatus, several transcriptional reg-
ulators were reported to be important for the pathogenesis of
V. vulnificus. An alternative sigma factor, RpoS, was shown to
be important for both the survival and virulence of this patho-
genic bacterium (11, 29). An experiment employing in vivo-
induced antigen technology identified the hlyU gene to be
induced during the infection process of V. vulnificus, which
encodes an activator for hemolysin production in V. cholerae
(39). In that study, deletion of this gene was found to cause a
dramatic decrease in bacterial cytotoxicity (16).
The first step in the microbial infection of host cells is me-
diated primarily by the interaction of the pathogen with con-
nective tissues or epithelial cells (6). Fibronectin (FN) is con-
sidered the most important extracellular matrix (ECM) protein
involved in cellular adherence (33), and it is one of the recep-
tors on epithelial cells for bacterial adherence (5). Regarding
the bacterial interaction with FN, gram-positive bacteria such
as Staphylococcus aureus and Streptococcus pyogenes have been
extensively investigated (reviewed in reference 34). In these
microorganisms, FN-binding proteins (FNBPs) with conserved
domains mediated bacterial adhesion to and invasion of host
cells. Deletion analysis of FNBPs of S. aureus localized primary
FN-binding sites, such as repeats of 35 to 40 residues in the
carboxyl-terminal part of the protein (8). Assays of invasion of
S. aureus cells into human corneal epithelial cells indicated that
inhibitors specifically blocking actin polymerization or tyrosine
kinase of host cells abolished bacterial entry into host cells
(13). This result suggested a model in which the invasion of S.
aureus into host cells required the activation of a signal cascade
including actin polymerization and tyrosine kinase and that
FNBP may serve as a trigger for the activation of this signaling
pathway.
In this study, we examined whether V. vulnificus may interact
with the ECM, and specifically with FN, and demonstrated the
adherence of V. vulnificus to immobilized FN. We then defined
the nature of a bacterial surface protein(s) interacting with FN.
* Corresponding author. Mailing address: Department of Parasitol-
ogy, Yonsei University School of Medicine, 134 Shinchon-dong, Seo-
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MATERIALS AND METHODS
Strains, plasmids, and culture cultivation. The strains and plasmids used in
this study are listed in Table 1. Escherichia coli strains used for plasmid DNA
preparation and the conjugational transfer of plasmid were grown in Luria-
Bertani (LB) broth or on LB plates containing 1.5% (wt/vol) agar. V. vulnificus
strains were grown in LB medium supplemented with 2% (wt/vol) NaCl (LBS),
unless stated otherwise. Ampicillin was added to the medium at 100 g ml1 for
the maintenance of plasmids in E. coli or at 300 g ml1 for the selection of V.
vulnificus exconjugants. All medium components were purchased from Difco,
and the chemicals and antibiotics were obtained from Sigma.
Assay of binding to the ECM. V. vulnificus strain MO6-24/O (41) was freshly
grown up to an optical density at 600 nm (OD600) of 1.0 in LBS at 30°C,
harvested by centrifugation at 7,000  g, and resuspended in phosphate-buffered
saline (PBS) (150 mM NaCl, 17 mM NaPO4, 1 mM EGTA, pH 7.0). Ninety-six-
well plates were coated with one of the ECM components (FN, collagen, or
laminin; Sigma) at a concentration of 100 g ml1 in PBS (4°C, 18 h). After
blocking the plates with bovine serum albumin (BSA) (1% for 1 h) at room
temperature (RT), 1  105 V. vulnificus cells were added to each of the coated
wells. After being washed four times with PBS–1% BSA, bound bacteria were
retrieved by resuspension in PBS–0.1% Triton X-100 at RT for 10 min and
counted by plating onto LBS agar. The 96-well plate with BSA instead of the
ECM components was used as a control.
Purification of a fibronectin-binding protein of V. vulnificus. Three hundred
milliliters of V. vulnificus MO6-24/O at an OD600 of 1.0 was resuspended in 10 ml
of PBS and lysed with a sonicator. Forty-eight-well culture plates were coated by
treatment with 50 g of FN at 4°C for 18 h and washed three times with PBS.
After blocking with PBS–1% BSA for 1 h, the plate was then washed twice with
PBS. Two hundred microliters of bacterial lysates (an equivalent of 2 mg
protein) was added to each well coated with FN, incubated for 3 h, and washed
six times with PBS to remove unbound proteins. Bound proteins on 48 wells were
released in 100 l of PBS–1% sodium dodecyl sulfate (SDS), pooled, and con-
centrated fivefold with Centricon (Amicon). The eluted proteins were separated
by 10% SDS-polyacrylamide gel electrophoresis (PAGE). The proteins were
transferred onto a polyvinylidene difluoride (PVDF) membrane and stained with
0.5% Ponceau (Sigma). The retrieved band was identified by amino-terminal
sequencing with a protein sequencing system (Milligen 6600).
Formation of OmpU-specific antibodies. Recombinant OmpU was overex-
pressed in Escherichia coli as described previously by Park et al. (28). Briefly, two
primers, ompU R-F (5-ATGGGCCCAAAGTCATCTTTGG-3) and ompU
R-R (5-GCGGATCCAATCTATCTAGAAT-3), were used to amplify a
1.63-kb DNA fragment containing the ompU gene and a 513-bp upstream region
from the genomic DNA of V. vulnificus MO6-24/O. This DNA was then cloned
into the pGEMT-Easy vector (Promega) to produce pDK1. Using two EcoRI
sites of pDK1 (one at position 232 from the start codon of ompU and the other
in the multicloning site), a 791-bp DNA fragment containing the 3-terminal
portion of ompU was isolated and cloned into pTrcHisB (Invitrogen), resulting
in a tagging of OmpU with six histidines. After being transformed into JM109,
recombinant OmpU was overexpressed and purified with a His-Bind kit
(Novagen).
Six-week-old female BALB/c mice were immunized intraperitoneally with 10
g of recombinant OmpU, which was emulsified 1:1 in Freund complete adju-
vant. The animals were boosted twice at 3-week intervals with the same amount
of OmpU protein emulsified in Freund incomplete adjuvant. A week after the
third immunization, blood samples of mice were pooled and used for further
experiments as polyclonal antibodies against recombinant V. vulnificus OmpU
(anti-OmpU). Blood samples were also obtained from nonimmunized mice and
then used as a control.
Assay of binding to RGD. Each well of 96-well culture plates was coated with
20 g of RGD tripeptide (NH2-Arg-Gly-Asp-COOH) (Takara) in PBS at 4°C for
18 h, blocked with PBS–1% BSA at RT for 1 h, and then washed three times with
PBS. A total of 1  105 cells of freshly grown V. vulnificus (OD600 of 0.7) were
added to each of the RGD-coated wells and incubated at RT for 30 min. After
being washed four times with PBS–1% BSA, the bound bacteria were retrieved,
serially 10-fold diluted, and then enumerated by plating onto LBS agar.
Treatment of V. vulnificus with OmpU-specific antibodies. To confirm the role
of OmpU in bacterial binding to FN or to host cells as well as in bacterial
cytotoxicity, wild-type V. vulnificus cells were preincubated with anti-OmpU
(20  40 g ml1) before being used for binding assays. As a control, wild-type
V. vulnificus cells were treated with the same concentrations of mouse preim-
mune serum instead of anti-OmpU.
Construction of ompU mutant and complementation strains. Using SphI-SpeI
sites present in pDK1, a 1,630-bp DNA fragment of pDK1 was subcloned into
pBluescript SK() (Stratagene) to yield pBS-DK1. After a 204-bp PstI DNA
fragment was deleted in the ompU gene, the SphI-SpeI DNA fragment of the
ompU-deleted plasmid (1,426 bp) was then cloned into the suicide vector pDM4
(21). The resultant construct, pDM-dU, was used to mutate the ompU gene in
wild-type V. vulnificus by allelic exchange to yield an ompU knockout V. vulnificus
strain, DK1. Deletion of the PstI fragment within the ompU gene caused the loss
of a portion of the protein (amino acid residues 15 to 82).
A 1,312-bp DNA was amplified from V. vulnificus genomic DNA using two
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) Source orreference
Strains
E. coli
DH5 supE44 lacU169 (	80 lacZ M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Laboratory
collection
SM10
pir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu
pir; OriT of RP4 Kmr; conjugational donor 20
JM109 recA1 supE44 endA1 hsdR17 gyrA96 relA1 thi (lac-proAB) F traD36 proAB lacIqZM15 44
V. vulnificus
MO6-24/O Clinical isolate 41
DK1 ompU mutant of MO6-24/O This study
Plasmids
pGEMT-Easy Vector used for cloning of PCR product Promega
pDK1 pGEMT-Easy ompU 28
pTrcHisB Expression vector for a histidine-tagged protein Invitrogen
pTrcompU pTrcHisB ompU 28
pBluescript SK() OriR6K OriT Apr rpsL Stratagene
pBS-DK1 pBluescript SK() ompU This study
pBS-dU pBS-DK1 ompU This study
pDM4 Suicide vector; OriR6K Cmr 21
pDM-dU pDM4 ompU This study
pCOS5 OriV OriT Apr Cmr cos 3
pJH0311 pCOS5, multicloning sites; Apr S. H. Choi
pSM1 pJH0311 ompU This study
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primers, ompU-F (5-CTAGGAGCTCCACAATCGAACAGTGTTCATA-3
[underlined bases indicate the SacI site]) and ompU-R (5-CTAGCCCGGGC
ATAGTGACAACCCAATCTAT-3 [underlined bases indicate the SmaI site]),
which contains an open reading frame and a 307-bp upstream region of the
ompU gene. This DNA fragment was then cloned into the corresponding site of
the broad-host-range vector pJH0311 to produce pSM1. This ompU-containing
plasmid was mobilized in V. vulnificus strain DK1 via conjugation. Strain DK1
carrying pJH0311 was also constructed in the same manner to serve as a control.
Western blot analysis. Lysates of various V. vulnificus cells (wild type, DK1,
DK1 with pJH0311, and DK1 with pSM1) were prepared by resuspending the
harvested cells in PBS and disrupting them with a sonicator. After centrifugation
at 12,000  g for 10 min, portions of the supernatants (50 g of protein per well)
were subjected to SDS-PAGE and then transferred onto a PVDF membrane.
The membranes were blocked with 5% nonfat dry milk in Tris-buffered saline
with 0.1% Tween 20 for 1 h at RT and then treated with OmpU antibodies at 4°C
overnight. Upon incubation with horseradish peroxidase-conjugated anti-mouse
immunoglobulin G, immunoreactive bands were visualized using an enhanced
chemiluminescence system (Cell Signaling).
Cell line adherence assay. Adherence assays were performed with the HEp-2
cell line derived from human laryngeal epithelial cells (Korean cell line number
10023) in 24-well culture plates. Each well of the culture plates was seeded with
105 HEp-2 cells and grown overnight at 37°C in the presence of 5% CO2. After
removing the medium and washing the cells twice with PBS, 1 ml of serum-free
Dulbecco’s modified Eagle medium (Gibco-BRL) was added to the HEp-2 cells.
Various V. vulnificus cells (wild type, DK1, DK1 carrying pJH0311, and DK1 with
pSM1) were grown at 30°C overnight in LBS broth. Cell monolayers were then
inoculated in triplicate with 50 l of the diluted bacteria to give a multiplicity of
infection (MOI) of 10 and incubated at 37°C in 5% CO2 for 30 min. The
monolayer was then washed five times with prewarmed PBS to remove nonad-
herent bacteria. Following the last wash, the HEp-2 cells were lysed with 0.1%
Triton X-100 treatment for 15 min. The bacteria were recovered from these cells
with PBS, serially 10-fold diluted, and then plated onto LBS agar.
Cytotoxicity assays. Cytotoxicity of V. vulnificus to HEp-2 cells was measured
using the CytoTox 96 Non-Radioactive Cytotoxicity assay kit (Promega). This
cytotoxicity kit measures the lactate dehydrogenase (LDH) activity released into
the culture medium by lysed cells. To measure the total LDH activity of the cell
lines used in the assays, Triton X-100 was added to a final concentration of 1.0%
(vol/vol) to lyse the host cells. The LDH activity was then determined by color-
imetric assay according to the manufacturer’s instructions and is represented as
a percentage of LDH activities relative to the total LDH activities of the cells
treated with 1% Triton X-100.
As a second assay to measure the cytotoxicity of V. vulnificus, the viability of
HEp-2 cells was also checked using propidium iodide (PI), which stains nucleic
acids of dead cells with disrupted membranes. Flow cytometric analysis to esti-
mate the percentage of cells stained with PI was performed on at least 5,000 cells
from each sample by fluorescence-activated cell sorting (FACScan; BD Bio-
sciences).
LD50 determination. For 50% lethal dose (LD50) determinations, specific-
pathogen-free, 7-week-old, female ICR mice were used without pretreatment
with iron-dextran. Cultures of bacterial strains grown overnight in LB medium
with 0.86% (wt/vol) NaCl were freshly cultivated in the same medium up to an
OD600 of 0.7, harvested, washed once in PBS, and then resuspended in
PBS–0.01% gelatin. One hundred microliters of serial dilutions of the bac-
terial suspension was then injected intraperitoneally into six mice per dilution
group. The numbers of dead mice were determined 24 h after the injection,
and the LD50 was calculated using the equation described previously by Reed
and Muench (32).
Statistical analyses. Results were expressed as the means  standard devia-
tions from three independent experiments. Statistical analysis was performed
using Student’s t test (SYSTAT program, SigmaPlot version 9; Systat Software
Inc.). Differences were considered significant if P values were 0.05. Data with
P values of 0.01 are indicated with two asterisks, whereas data with P values
between 0.01 and 0.05 are indicated with one asterisk.
RESULTS
Binding of V. vulnificus to ECM components. We examined
the ability of V. vulnificus to adhere to three components of
ECM, collagen, fibronectin, and laminin (Fig. 1). In contrast to
the low number of bacterial cells bound to the coated BSA
(3.4% of the added bacteria), higher numbers of bacteria were
retained on coated fibronectin and collagen. However, the
percentage of bacteria that bound to laminin was similar to
FIG. 1. Adherence of Vibrio vulnificus to various components of
the extracellular matrix. Wild-type V. vulnificus cells (1  105) were
added to a multiwell plate coated with one of three extracellular matrix
proteins at a concentration of 100 g ml1 and incubated for 10 min.
Assay of binding of V. vulnificus to each component was performed
eight times. The percentages of bacterial cells that adhered to wells
coated with BSA (an open bar), fibronectin (a black bar), collagen (a
hatched bar), or laminin (a crosschecked bar) were determined by
plating the eluted bacteria onto LBS agar. Error bars represent the
means  standard deviations from three independent experiments.
The asterisk indicates a binding level that was significantly different
from that of the BSA-coated control by Student’s t test.
FIG. 2. Adherence of Vibrio vulnificus to fibronectin- or BSA-
coated surfaces. Wild-type V. vulnificus cells were added to the mul-
tiwell plate coated with various concentrations (5, 10, 50, and 100 g
ml1) of fibronectin or BSA and incubated for 10 min. The percent-
ages of bacterial cells that adhered to wells coated with BSA (filled
circles) or fibronectin (open circles) were determined by counting
CFU on LBS agar plates. Assay of binding of V. vulnificus to fibronec-
tin or BSA at each concentration was performed eight times. Error
bars represent the means  standard deviations from three indepen-
dent experiments. Asterisks indicate binding levels that were signifi-
cantly different from those of the BSA-coated control at the corre-
sponding concentration by the Student’s t test. Data with P values of
0.01 are indicated with two asterisks, whereas data with P values of
between 0.01 and 0.05 are indicated with one asterisk.
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that of bacteria that adhered to BSA (4.1% of the added V.
vulnificus cells). Despite the higher bacterial affinity for colla-
gen (13% of the added bacteria), the number of bound bacte-
ria was not statistically different from that of bacteria bound to
BSA. Numbers of bacteria that bound to FN (18%  3.3% of
the added bacteria) were significantly higher (P  0.002) than
the numbers of bacteria that bound to BSA.
Binding of V. vulnificus to immobilized FN was further ex-
amined in subsequent experiments. The numbers of bacteria
that bound to an FN-coated surface increased in a dose-de-
pendent manner (Fig. 2). The percentage of bacteria that
bound to the immobilized FN was increased up to 14% at 100
g ml1 of FN. On the other hand, less than 3% of added
bacteria were retained on the surface coated with BSA regard-
less of the amount of BSA used.
Identification of the OmpU protein as a fibronectin-binding
protein of Vibrio vulnificus. Binding of V. vulnificus to FN led us
to identify a bacterial protein involved in this process. A pro-
tein of about 35 kDa was retrieved from lysates of V. vulnificus
MO6-24/O by its affinity for FN-coated surfaces (Fig. 3). The
sequence of the first 21 amino acids at the amino terminus of
the isolated protein was AELYNQDGTSLDMGGRAEARL.
A TBlast search using this partial sequence showed complete
identity to the OmpU proteins of both V. vulnificus strain
CMPC6 (GenBank accession number AE016802.1) and V.
vulnificus strain YJ016 (accession number BA000037.2). In the
analysis of the proteins isolated from FN-binding assays, we
could not observe the protein bands corresponding to FN
(200  250 kDa [plasma FN] or 550 kDa [cellular FN]) on
a PVDF membrane, possibly due to the low efficiency of
blotting of these proteins with high molecular weights.
Role of OmpU protein in binding of V. vulnificus to the
immobilized FN and to immobilized RGD tripeptide. The
function of OmpU in the FN binding of V. vulnificus was
assessed using an ompU knockout mutant. The V. vulnificus
ompU mutant was made by removing a PstI DNA fragment of
204 bp, which is present within an open reading frame of the
ompU gene. The mutant results in a loss of a portion of the
amino acids from residues 15 to 82 of OmpU.
ompU mutant strain DK1 was verified by Western blot anal-
ysis using anti-OmpU (Fig. 4A). While OmpU was detected in
lysates of wild-type V. vulnificus strain MO6-24/O, the immu-
noreactive band was not present in lysates of DK1. The intact
ompU gene was added back to ompU mutant strain V. vulnifi-
cus DK1 as a pJH0311-based plasmid, pSM1. Strain DK1,
containing pJH0311, was also constructed as a control strain.
Expression of the OmpU protein in the complemented strain
was also shown in Western blots using anti-OmpU, whereas
the OmpU protein was not detected in the control strain, DK1
harboring pJH0311 (Fig. 4B).
The ability of this ompU mutant to bind to FN was compared
with that of the wild-type strain (Fig. 5A). While a significant
FIG. 3. Identification of a fibronectin-binding protein of Vibrio vulni-
ficus. A crude lysate of wild-type V. vulnificus was added to a multiwell
plate coated with 50 g of fibronectin and incubated for 3 h. After being
washed with PBS, the proteins bound to the fibronectin-coated surface
were eluted with 1% sodium dodecyl sulfate and concentrated fivefold
with Centricon as described in Materials and Methods. Upon separation
by 10% SDS-PAGE and transfer to a PVDF membrane, the eluted
proteins were visualized by Ponceau. A protein of 35 kDa was excised and
subjected to N-terminal amino acid sequencing.
FIG. 4. Western blot analysis using polyclonal antibodies against
the recombinant OmpU protein (anti-OmpU). (A) Confirmation of
ompU mutant V. vulnificus by Western blot analysis. Lane 1, lysate of
wild-type V. vulnificus MO6-24/O; lane 2, lysate of DK1, an ompU
mutant of V. vulnificus. (B) Confirmation of the ompU complementa-
tion strain by Western blot analysis. Lane 1, lysate of DK1 harboring
a broad-host-range vector, pJH0311; lane 2, lysate of DK1 harboring
pSM1, a complementation plasmid of the wild-type ompU gene. Ly-
sates of four different strains of V. vulnificus were prepared as de-
scribed in Materials and Methods. Fifty micrograms of protein was
subjected to SDS-PAGE per each sample and transferred onto a
membrane. After being blocked with 5% nonfat dry milk, the mem-
brane was incubated with mouse antibodies against the recombinant
OmpU and was then incubated with horseradish peroxidase-conju-
gated anti-mouse immunoglobulin G. Immunoreactive proteins were
visualized using an enhanced chemiluminescence system. MW, molec-
ular weight (in thousands).
VOL. 74, 2006 FIBRONECTIN-BINDING PROTEIN OF VIBRIO VULNIFICUS 5589
 o
n
 June 18, 2014 by YO
NSEI UNIV M
ED LIBRARY
http://iai.asm
.org/
D
ow
nloaded from
 
portion of the added wild type was bound to FN in a dose-
dependent manner (13%), the ability to bind to FN was
significantly disrupted in the ompU mutant strain; that is,
0.55% of the added mutant bacteria were bound to the FN-
coated surface.
Evidence for the involvement of OmpU of V. vulnificus in
FN binding was strengthened by an additional experiment us-
ing anti-OmpU. Preincubation of wild-type V. vulnificus with
anti-OmpU at concentration of 20 g ml1 significantly de-
creased the bacterial binding of 3.3% of the added bacteria to
FN (Fig. 5B). On the other hand, pretreatment of wild-type V.
vulnificus with the same concentration of mouse preimmune
serum did not result in any alteration of the bacterial binding
to FN (13%).
The FN-binding ability of the ompU-complemented
strain, DK1(pSM1), was also examined (Fig. 5A). The abil-
ity of the bacteria to adhere to FN was fully restored when
the intact ompU gene was added to the ompU mutant strain.
As expected, the presence of a vector plasmid, pJH0311, did
not alter the inability of the ompU knockout strain to adhere
to FN.
It is well known that FN-binding proteins bind to FN by
specific interactions with the RGD repeat of FN (9). When we
examined whether V. vulnificus could bind to immobilized
RGD tripeptide, we found that a significant portion of V.
vulnificus cells (55% of the added bacteria) was bound to the
RGD tripeptide (Fig. 6A). On the other hand, the ability of
bacteria to adhere to RGD was almost abolished in the case of
ompU knockout mutant DK1 (2.7% of the added bacteria).
Wild-type V. vulnificus was treated with 20 g ml1 of anti-
OmpU or mouse preimmune serum and then tested for bind-
ing to RGD tripeptides (Fig. 6B). Twenty-four percent of V.
vulnificus cells adhered to RGD when they were treated with
preimmune serum. On the contrary, only 6.5% of bacteria
were bound to RGD if they were incubated with anti-OmpU.
In the same manner, an addition of the intact ompU gene into
strain DK1 also endowed binding ability to RGD tripeptide to
up to 52% of that of wild-type V. vulnificus (Fig. 6A).
Role of OmpU in cytoadherence of V. vulnificus. Based on
the observation that OmpU may serve as a ligand for FN, we
extended our experiments to reveal the function of this protein
in interactions with host cells. The first assay that we per-
formed was an examination of the role of OmpU in bacterial
FIG. 5. Role of the OmpU protein in adherence of Vibrio vulnificus
to immobilized fibronectin. (A) Adherence of various V. vulnificus
strains to fibronectin. V. vulnificus cells (wild-type V. vulnificus MO6-
24/O [open bar], ompU mutant strain DK1 [closed bar], DK1 carrying
pJH0311 [gray bar], and DK1 carrying a complementation plasmid,
pSM1 [hatched bar]) were added to a 96-well plate coated with fi-
bronectin. The percentage of bacterial cells that adhered to fibronec-
tin-coated wells was determined by plating bound bacteria onto LBS
agar. Error bars represent the means  standard deviations from three
independent experiments. Assay of the binding of each V. vulnificus
strain to fibronectin was performed in quadruplicate for each experi-
ment. Asterisks indicate binding levels that were significantly different
from that of wild-type V. vulnificus by the Student’s t test. Data with P
values of 0.01 are indicated with two asterisks, whereas data with P
values of between 0.01 and 0.05 are indicated with one asterisk. (B) In-
hibition of fibronectin binding of wild-type V. vulnificus by anti-OmpU.
The percentage of bacterial cells that adhered to fibronectin-coated
wells was determined for wild-type V. vulnificus preincubated with
mouse preimmune serum (dotted bar) or with anti-OmpU (cross-
hatched bar) at 20 g ml1. Error bars represent the means  stan-
dard deviations from three independent experiments. Assay of binding
of V. vulnificus to fibronectin was performed in quadruplicate for each
experiment. The asterisk indicates a binding level that was significantly
different from that of wild-type V. vulnificus pretreated with mouse
preimmune serum by Student’s t test (0.01  P  0.05). Ab, antibody.
FIG. 6. Role of OmpU protein in adherence of Vibrio vulnificus to
immobilized RGD tripeptide. (A) Adherence of various V. vulnificus
strains to the RGD tripeptide. V. vulnificus cells (wild-type V. vulnificus
MO6-24/O [open bar], ompU mutant DK1 [closed bar], DK1 carrying
pJH0311 [gray bar], and DK1 carrying a complementation plasmid,
pSM1 [hatched bar]) were added to the 96-well plate coated with RGD
tripeptide. Each well of the culture plate was coated with 20 g of
RGD tripeptide in PBS at 4°C for 18 h. V. vulnificus cells (1  105)
were added to each of the RGD-coated wells and incubated at RT for
30 min. The percentage of bacterial cells that adhered to RGD-coated
wells was determined by counting CFU of the eluted bacteria on LBS
agar plates. Error bars represent the means  standard deviations
from three independent experiments. Assay of binding of V. vulnificus
to RGD tripeptide was performed in quadruplicate for each experi-
ment. Asterisks indicate binding levels that were significantly different
from that of wild-type V. vulnificus by Student’s t test. Data with P
values of 0.01 are indicated with two asterisks, whereas data with P
values of between 0.01 and 0.05 are indicated with one asterisk. (B) In-
hibition of RGD binding of wild-type V. vulnificus by anti-OmpU. The
percentage of bacterial cells that adhered to RGD-coated wells was
determined for wild-type V. vulnificus preincubated with mouse pre-
immune serum (dotted bar) or with anti-OmpU (cross-hatched bar) at
20 g ml1. Error bars represent the means  standard deviations
from three independent experiments. Assay of binding of V. vulnificus
to RGD tripeptide was performed in quadruplicate for each experi-
ment. Asterisks indicate binding levels that were significantly different
(P  0.01) from that of wild-type V. vulnificus pretreated with mouse
preimmune serum by Student’s t test. Ab, antibody.
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adherence to the HEp-2 epithelial cell line (Fig. 7A). When
the ratio of bacteria to HEp-2 cells was 10:1, the percentage of
adhered bacteria of the initially added bacteria was 2.7% in the
case of the assay of HEp-2 cells with wild-type V. vulnificus. In
the case of the assay with the ompU mutant, the portion of the
bacterial cells that adhered to the HEp-2 cells was quite low,
e.g., 0.18% of the added bacteria.
The role of OmpU in the cytoadherence of wild-type V.
vulnificus was confirmed using anti-OmpU (Fig. 7B). Wild-type
V. vulnificus cells were treated with either 20 or 40 g ml1 of
anti-OmpU prior to the adherence tests while the ratio of
bacteria to HEp-2 cells was kept at 10:1. As a control, wild-type
V. vulnificus cells were also incubated with mouse preimmune
serum at the same concentrations and used for the adherence
tests. In the case of wild-type V. vulnificus cells preincubated
with anti-OmpU, they showed decreased levels of cytoadher-
ence in a dose-dependent manner, down to 0.77% of the anti-
OmpU-treated cells. In contrast, 2.6 or 2.9% of the added V.
vulnificus cells adhered to the cell lines when they were treated
with 20 or 40 g ml1 preimmune serum, respectively.
In addition, the cytoadherence of strain DK1 to HEp-2 cells
was fully recovered to wild-type levels when it carried pSM1,
an ompU plasmid, whereas the introduction of pJH0311 to
strain DK1 did not cause any change in bacterial adherence to
HEp-2 cells (Fig. 7A).
Role of OmpU in cytotoxicity of V. vulnificus. In a subsequent
experiment, we asked whether the defects in FN binding as
well as in cytoadherence of the ompU mutant could affect
bacterial virulence toward host cells. Incubation of wild-type V.
vulnificus cells at an MOI of 50 or 100 resulted in 37% or 79%
cytotoxicity of host cells, respectively, when determined by
LDH release assay (Fig. 8A). On the other hand, the V. vulni-
ficus ompU mutant was significantly less cytotoxic than wild-
type V. vulnificus (14% and 32% at MOIs of 50 and 100,
respectively).
Upon incubation with either wild-type or ompU V. vulnificus,
the viability of HEp-2 cells was also checked by staining the
dead cells with PI (Fig. 8B). Without the addition of V. vulni-
ficus, 4.0 to 4.4% of HEp-2 cells were stained with PI,
whereas the percentages of PI-stained cells exposed to wild-
type V. vulnificus increased to 18 and 42% at MOIs of 10 and
20, respectively. When HEp-2 cells were incubated with the
V. vulnificus ompU mutant at MOIs of 10 and 20, only 5.1
and 9.4% of HEp-2 cells, respectively, were stained with PI.
These values are significantly less than those found with the
wild type.
In the subsequent experiments, we examined whether atten-
uated phenotypes of strain DK1 in cytotoxicities to HEp-2 cell
lines could be recovered to the wild-type phenotype by intro-
ducing pSM1. In the assays for measuring bacterial cytotoxic-
FIG. 7. Role of OmpU protein in adherence of Vibrio vulnificus to HEp-2 cells. (A) Cytoadherence of various V. vulnificus strains to HEp-2
cells. V. vulnificus cells (wild-type V. vulnificus MO6-24/O [open bar], ompU mutant DK1 [closed bar], DK1 carrying pJH0311 [gray bar], and DK1
carrying a complementation plasmid, pSM1 [hatched bar]) were added to HEp-2 cells at an MOI of 10 and incubated for 30 min. Following five
washes with PBS, the HEp-2 cells were treated with 0.1% Triton X-100 for 15 min. The percentage of bacterial cells that adhered to HEp-2 was
determined by measuring CFU of the retrieved bacteria on LBS agar plates. Assay of adherence of various V. vulnificus cells to HEp-2 was
performed in quadruplicate, and data are presented with error bars, which are standard deviations of three independent experiments. Asterisks
indicate binding levels that were significantly different from that of wild-type V. vulnificus by Student’s t test. Data with P values of 0.01 are
indicated with two asterisks, whereas data with P values of between 0.01 and 0.05 are indicated with one asterisk. (B) Inhibition of cytoadherence
of wild-type V. vulnificus cells to HEp-2 cells by anti-OmpU. Prior to the cytoadherence test, wild-type V. vulnificus cells were treated with either
antibodies against recombinant OmpU (OmpU Ab) (cross-hatched bars) or mouse preimmune serum (dotted bars) for 30 min at two different
concentrations (20 or 40 g ml1). The percentage of bacterial cells that adhered to HEp-2 cells was determined by measuring CFU of the adhered
bacteria on LBS plates. Each cytoadherence assay was done in quadruplicate, and data are presented along with standard deviations of three
independent experiments. Asterisks indicate binding levels that were significantly different (P 0.01) from that of wild-type V. vulnificus pretreated
with mouse preimmune serum by the Student’s t test.
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ities, strain DK1 carrying pSM1 showed 91 to 98% of the
cytotoxicities of wild-type V. vulnificus (Fig. 8A and B). On the
other hand, the control strain (strain DK1 with a vector,
pJH0311) showed cytotoxicities similar to that of strain DK1 in
both LDH and PI staining assays.
Role of OmpU in lethality of V. vulnificus to mice. We ex-
amined the role of the V. vulnificus OmpU protein in patho-
genesis by using a mouse infection model. Upon intraperito-
neal injection of various numbers of bacterial cells into mice,
the numbers of dead mice were determined 24 h after the
injection (Table 2). One of the experiments was presented as a
representative experiment. Mice infected with the wild type
showed an LD50 of 3.4  10
3 cells, whereas mice injected with
the ompU mutant showed a 10-fold-higher LD50, i.e., 3.4  10
4
cells.
The complemented and the control strains were also tested
for their LD50 values in a mouse model. A higher number of
the control strain, DK1 carrying pJH0311, was required to
achieve 50% killing (1.0  105 cells), as the ompU mutant
strain did. To obtain 50% lethality of mice by the comple-
mented strain, 1.9  104 cells (which is 5.5 times more wild-
type cells) were need, suggesting that the introduction of the
wild-type ompU gene into DK1 caused a partial complemen-
tation in mouse virulence.
DISCUSSION
The capability of bacterial adherence to the host cells is an
important virulence factor for many pathogens, including V.
vulnificus. The severe and rapid cytopathological characteris-
tics of V. vulnificus infection make this organism a model
system to investigate host-pathogen interactions. In adhesion
assays using immobilized ECM components, V. vulnificus
showed an ability to bind to FN (Fig. 1), suggesting that it may
possess a surface protein(s) that interacts with this host com-
ponent. In a subsequent experiment to isolate the adherence
factor of V. vulnificus binding to FN, the OmpU protein, one of
the outer membrane proteins, was identified (Fig. 3).
OmpU has been extensively studied in V. cholerae, a patho-
gen that colonizes the human intestine and produces cholera
disease (25). The expression of ompU, encoding outer mem-
brane porin in V. cholerae, is positively regulated by ToxR, the
key regulator of cholera toxin production and other virulence
determinants (4). Through a genetic construction of V. chol-
erae overexpressing OmpT, the other major outer membrane
porin, the ToxR-dependent modulation of two outer mem-
brane porins, OmpU and OmpT, was found to be important
for the expression of virulence factors and intestinal coloniza-
tion by V. cholerae (30). Interestingly, V. cholerae OmpU was
previously found to be an FN-binding protein and was sug-
FIG. 8. Role of the OmpU protein of Vibrio vulnificus in bacterial
cytotoxicity to HEp-2 cells. (A) Determination of cytotoxicity of various V.
vulnificus strains by estimating the activity of LDH. Using a CytoTox96
assay kit, LDH released from the HEp-2 cells was measured upon incu-
bation with wild-type V. vulnificus (open bars), ompU mutant DK1 (black
bars), DK1 carrying pJH0311 (gray bars), or DK1 carrying pSM1 (hatched
bars). HEp-2 cells (1  105) were incubated with V. vulnificus cells for 30
min at two different MOIs, 50 and 100. Each assay was performed in
quadruplicate and repeated three times. The data are shown with error
bars, which are standard deviations of three independent experiments.
Asterisks indicate enzyme activities that were significantly different (P 
0.01) from that of wild-type V. vulnificus by Student’s t test. (B) Determi-
nation of the cytotoxicities of various V. vulnificus strains by staining with
PI. The percentages of dead HEp-2 cells during incubation with wild-type
V. vulnificus (open bars), ompU mutant strain DK1 (black bars), DK1
carrying pJH0311 (gray bars), or DK1 carrying pSM1 (hatched bars) were
measured at two different MOIs, 10 and 20. HEp-2 cells not exposed to V.
vulnificus were also stained with PI (dotted bars). Error bars represent the
means standard deviations from three independent experiments. Asterisks
indicate percentages of PI-stained cells that were significantly different (P
0.01) from that of wild-type V. vulnificus cells by Student’s t test.
TABLE 2. LD50s of Vibrio vulnificus
Strain Genotype
No. of dead mice/no. of total mice for no. of injected bacteria LD50
(CFU)3.4  10 3.4  102 3.4  103 3.4  104
MO6-24/O ompU 1/6 3/6 5/6 6/6 3.4  103
DK1 ompU 0/6 0/6 3/6 6/6 3.4  104
DK1(pJH0311) ompU 0/6 0/6 1/5 5/1 1.0  105
DK1(pSM1) ompU 0/6 0/6 4/6 6/6 1.9  104
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gested to be a potential adherence factor in V. cholerae (37). In
that study, OmpU protein selectively bound to FN and to an
arginine-glycine-asparagine (RGD) tripeptide. Subsequent
studies, however, indicated that OmpU was not involved in the
adherence of V. cholerae to the brush border of the rabbit small
intestine (25, 31). In contrast, OmpU was reported to be an
important colonization factor in Vibrio fischeri to establish
mutualistic symbiosis within a light organ of its squid host,
Euprymna scolopes; however, its affinity for FN was not
reported (1). It is likely that OmpU proteins in Vibrio spp.
may function as a component of the adhesion apparatus via
their affinity for FN. Sequence comparison of OmpU pro-
teins indicates that this protein is conserved in various
Vibrio spp. including V. cholerae, V. parahaemolyticus, V.
fischeri, V. splendidus, and V. vulnificus. The identities of
amino acid sequences range from 59 to 76% among OmpU-
homologous proteins.
Our study using an ompU knockout V. vulnificus mutant and
antibodies against OmpU clearly shows that the OmpU pro-
tein of V. vulnificus is involved in FN binding (Fig. 4). Adher-
ence and cytotoxicity assays (Fig. 5, 6, and 7) demonstrated
that V. vulnificus cells interact with the host cell epithelium via
a direct interaction between bacterial OmpU and FN of the
host cells at the early stage of infection. Failure of the ompU
mutant of V. vulnificus to adhere to host cells apparently re-
sults in defects in bacterial cytotoxicity against host cells. In
gram-positive bacteria, several FNBPs had been reported as
major virulence factors: FNBPA and FNBPB for S. aureus (14,
36), Sfb1 for Streptococcus pyogenes (23), and CshA for Strep-
tococcus gordonii (18). A current model for the function of
these FNBPs suggested that the binding of FNBP with multiple
FNs resulted in the localization of integrin binding sites, which
induce the clustering of integrins in the membrane of host cells
(34). The clustering of integrin in host cells may trigger the
phosphorylation of tyrosine kinase and actin rearrangement,
which are essential for the internalization of bacteria into host
cells (13). In the case of Streptococcus pyogenes, two distinct
cellular mechanisms were proposed for Sfb1-negative and
Sfb1-positive strains with respect to the involvement of integrin
in bacterial invasion (23). In contrast, nothing is known about
the exact mechanism(s) by which OmpU facilitates the patho-
genesis of V. vulnificus, and further investigations should be
performed to evaluate the contribution of the OmpU-FN in-
teraction to the processes causing disease in humans by V.
vulnificus.
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